Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials

Author: Higashijima Yoshiki   Tanaka Tetsuhiro   Nangaku Masaomi  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.8, Iss.8, 2013-11, pp. : 965-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content